Simple Wastewater Preparation Protocol Applied to Monitor the Emergence of the Omicron 21L/BA.2 Variant by Genome Sequencing.

Omicron SARS-CoV-2 genomics next-generation sequencing protocol qPCR sewage variant

Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
17 01 2023
Historique:
received: 24 11 2022
revised: 22 12 2022
accepted: 16 01 2023
entrez: 28 2 2023
pubmed: 1 3 2023
medline: 3 3 2023
Statut: epublish

Résumé

Detecting and monitoring viruses in wastewater samples have been reported as useful ways of tracking SARS-CoV-2 epidemic trends. However, there is currently no unanimously recognised method of processing samples to identify and quantify SARS-CoV-2 variants in wastewater. We aimed to implement a method that was as simple as possible in order to be used universally. In a study performed between January 2022 and June 2022 in the city of Marseille, France, we first evaluated the impact of the sample preservation strategy. We then compared ultracentrifugation to ultrafiltration and several steps of filtration to determine the optimal approach for virus concentration. As a proof-of-concept, the definitive protocol was applied to next-generation sequencing of SARS-CoV-2 in wastewater to monitor the emergence of the Omicron variant in the city. For sewage water to be processed in the week following the sampling, storage at +4 °C is sufficient, with less than 1 Ct loss. Filtration with a 5 µm syringe filter, then with a 0.8 µm filtration unit, followed by ultrafiltration was the optimal protocol, leading to an average increase of 3.24 Ct when the starting Ct was on average 38 in the wastewater. This made it possible to observe the emergence of the Omicron 21L/BA.2 variant after Omicron 21K/BA.1 by genome sequencing over a period ranging from 20 February to 10 April 2022 in agreement with observations based on patient data. To conclude, by using a simple method requiring only basic filters and a centrifuge as equipment, it is possible to accurately track the relative incidence rates and the emergence of SARS-CoV-2 variants based on sewage samples.

Identifiants

pubmed: 36851484
pii: v15020268
doi: 10.3390/v15020268
pmc: PMC9965846
pii:
doi:

Substances chimiques

Wastewater 0
Sewage 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Références

Front Microbiol. 2021 May 17;12:664477
pubmed: 34079532
Viruses. 2022 Sep 13;14(9):
pubmed: 36146835
Nat Rev Gastroenterol Hepatol. 2021 Apr;18(4):269-283
pubmed: 33589829
Pathogens. 2021 Aug 17;10(8):
pubmed: 34451505
BMJ. 2021 Mar 9;372:n579
pubmed: 33687922
J Med Virol. 2022 Jun;94(6):2360-2364
pubmed: 35150013
Science. 2021 May 21;372(6544):815-821
pubmed: 33853970
Balkan Med J. 2020 Apr 13;37(4):229-230
pubmed: 32279479
Sci Total Environ. 2021 Mar 1;758:143870
pubmed: 33338788
Sci Total Environ. 2020 Oct 1;737:140405
pubmed: 32783878
Viruses. 2022 Sep 02;14(9):
pubmed: 36146757
J Clin Med. 2021 Jun 18;10(12):
pubmed: 34207314
Lancet Reg Health Eur. 2021 Nov;10:100202
pubmed: 34423327
Curr Opin Environ Sci Health. 2020 Oct;17:49-71
pubmed: 33024908
J Virol Methods. 2021 Nov;297:114230
pubmed: 34252511
Pathogens. 2021 Sep 18;10(9):
pubmed: 34578246
J Clin Virol. 2022 Dec;157:105299
pubmed: 36183546
Sci Total Environ. 2021 Mar 15;760:144215
pubmed: 33340739
Sci Total Environ. 2022 May 15;821:153228
pubmed: 35090920
Sci Total Environ. 2022 Mar 1;810:152213
pubmed: 34896511
Emerg Infect Dis. 2021 May;27(5):1405-1415
pubmed: 33900177
Sci Total Environ. 2020 Oct 15;739:139960
pubmed: 32758945
Water Res. 2021 Jun 1;197:117043
pubmed: 33784608
Sci Total Environ. 2021 Feb 10;755(Pt 1):142939
pubmed: 33121776
BMJ. 2022 Jan 31;376:o263
pubmed: 35101887
Microbiol Resour Announc. 2021 Apr 15;10(15):
pubmed: 33858934
Science. 2021 Apr 9;372(6538):
pubmed: 33658326
mBio. 2021 Jan 19;12(1):
pubmed: 33468686
Curr Opin Environ Sci Health. 2020 Oct;17:21-28
pubmed: 32839746
Water Res. 2021 Jun 1;197:117104
pubmed: 33857895
Science. 2021 Mar 12;371(6534):1103-1104
pubmed: 33707254
Sci Total Environ. 2021 May 10;768:144786
pubmed: 33429117
Gastroenterology. 2020 May;158(6):1518-1519
pubmed: 32142785
Water Res. 2020 Aug 15;181:115942
pubmed: 32425251
Clin Infect Dis. 2023 Feb 8;76(3):e514-e517
pubmed: 35796540
Euro Surveill. 2020 Dec;25(50):
pubmed: 33334397
Cell Rep Med. 2020 Sep 22;1(6):100098
pubmed: 32904687
Sci Total Environ. 2020 Sep 20;736:139652
pubmed: 32464333
Nature. 2021 May;593(7858):266-269
pubmed: 33767447
Front Microbiol. 2022 Feb 07;12:786233
pubmed: 35197938
Ann Intern Med. 2021 May;174(5):655-662
pubmed: 33481642
Eur Rev Med Pharmacol Sci. 2021 Dec;25(24):8019-8022
pubmed: 34982466
Water Sci Technol. 2021 Dec;84(12):3508-3514
pubmed: 34928822
Gastroenterology. 2020 May;158(6):1831-1833.e3
pubmed: 32142773
Environ Sci (Camb). 2021 Jan 20;7:504-520
pubmed: 34017594

Auteurs

Nathalie Wurtz (N)

MEPHI, Institut de Recherche pour le Développement (IRD), Aix-Marseille Université, 13005 Marseille, France.
Institut Hospitalo-Universitaire Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13005 Marseille, France.

Maelle Boussier (M)

MEPHI, Institut de Recherche pour le Développement (IRD), Aix-Marseille Université, 13005 Marseille, France.
Institut Hospitalo-Universitaire Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13005 Marseille, France.

Louis Souville (L)

MEPHI, Institut de Recherche pour le Développement (IRD), Aix-Marseille Université, 13005 Marseille, France.
Institut Hospitalo-Universitaire Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13005 Marseille, France.

Gwilherm Penant (G)

Assistance Publique-Hôpitaux de Marseille (AP-HM), Aix-Marseille Université, 13005 Marseille, France.

Alexandre Lacoste (A)

Bataillon des Marins Pompiers de la ville de Marseille, 13005 Marseille, France.

Philippe Colson (P)

MEPHI, Institut de Recherche pour le Développement (IRD), Aix-Marseille Université, 13005 Marseille, France.
Institut Hospitalo-Universitaire Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13005 Marseille, France.
Assistance Publique-Hôpitaux de Marseille (AP-HM), Aix-Marseille Université, 13005 Marseille, France.

Bernard La Scola (B)

MEPHI, Institut de Recherche pour le Développement (IRD), Aix-Marseille Université, 13005 Marseille, France.
Institut Hospitalo-Universitaire Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13005 Marseille, France.
Assistance Publique-Hôpitaux de Marseille (AP-HM), Aix-Marseille Université, 13005 Marseille, France.

Sarah Aherfi (S)

MEPHI, Institut de Recherche pour le Développement (IRD), Aix-Marseille Université, 13005 Marseille, France.
Institut Hospitalo-Universitaire Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13005 Marseille, France.
Assistance Publique-Hôpitaux de Marseille (AP-HM), Aix-Marseille Université, 13005 Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH